1 / 12

Introduction

Intranasal Midazolam vs Rectal Diazepam for the Home Treatment of Acute Seizures in Pediatric Patients With Epilepsy.

swain
Télécharger la présentation

Introduction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Intranasal Midazolam vs Rectal Diazepam for the Home Treatment of Acute Seizures in Pediatric Patients With Epilepsy Holsti M, Dudley N, Schunk J, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010;164(8):747-753.

  2. Introduction • Rectal diazepam (RD) is a rescue medication frequently prescribed for the home treatment of seizures. • Intranasal midazolam has also been used as a home rescue medication for the treatment of seizures. • The Mucosal Atomization Device has been developed for nasal drug delivery. • We sought to compare the effectiveness of the Intranasal Midazolam Mucosal Atomization Device (IN-MMAD) with that of RD for the home treatment of seizures in children with epilepsy.

  3. Methods • Patients who visited a pediatric neurology clinic were identified and enrolled from July 2006 through September 2008. • Prospective randomized trial; not blinded. • Inclusion criteria: • Aged <18 years, with diagnosis of epilepsy. • Pediatric neurologist to send patient home with rescue medication for his or her next seizure. • Exclusion criteria: • Patients who receive home treatment with benzodiazepines other than diazepam or midazolam (ie, lorazepam).

  4. Methods • Primary outcome measure: seizure duration after administration of study medication. • Analyzed by Wilcoxon rank sum test. • Limitations: • Variability in seizure start times and stop times. • Potential selection bias. • Some caretakers decided not to participate when told they could not choose the study medication. • Experience. • Some caretakers had more experience treating seizures at home.

  5. Results

  6. Results

  7. Results

  8. Results

  9. Results

  10. Comment • There was no difference between IN-MMADand RD in terminating pediatric seizures at home and no differences in complications. • Ease of administration and overall satisfaction were higher in the IN-MMADgroup compared with the RD group.

  11. Comment Future Directions • IN-MMADmay be a good alternative for older pediatric patients with seizures. • Patients/caretakers may not want not to receive/give medications rectally. • The intranasal volume may limit the maximum amount given to an older patient. • IN-MMADmay be a less expensive alternative for the treatment of seizures. • Cost analysis must be done. • IN-MMADmay be difficult to give to young children with congestion unless suctioning is available.

  12. Contact Information • If you have questions, please contact the corresponding author: Maija Holsti, MD, MPH (maija.holsti@hsc.utah.edu). Funding/Support • This study was supported by Primary Children’s Medical Center Foundation, Salt Lake City, Utah.

More Related